Literature DB >> 16174715

Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

Masa-aki Kawashiri1, Toshinori Higashikata, Mihoko Mizuno, Mutsuko Takata, Shoji Katsuda, Kenji Miwa, Tsuyoshi Nozue, Atsushi Nohara, Akihiro Inazu, Junji Kobayashi, Junji Koizumi, Hiroshi Mabuchi.   

Abstract

CONTEXT: Lipoprotein lipase (LPL) deficiency is a rare autosomal recessive disorder caused by LPL gene mutation and is characterized by severe hyperchylomicronemia. Patients with LPL deficiency suffer from the frequent recurrence of acute pancreatitis, but the underlying mechanisms are not fully understood. CASE REPORT: A 22-yr-old male Japanese patient with severe hyperchylomicronemia was admitted to our hospital in 1973. He had no consanguinity and no family history of hyperlipidemia. He was genetically diagnosed as LPL deficiency (homozygous for LPL(Arita)) with no LPL mass or activity in postheparin plasma. He has experienced recurrent acute pancreatitis 22 times during our 31-yr clinical follow-up, but no pancreatic pseudocyst, irregularity of the pancreatic duct, or abnormal pancreatic calcification was observed in computed tomography. Moreover, his pancreatic endocrine function, as assessed by the oral glucose tolerance test, has preserved more than 30 yr. Although he was a current smoker, no clinically significant atherosclerotic lesion had been observed.
CONCLUSIONS: From the long-term observation of this patient, we propose that LPL deficiency is not invariably associated with high mortality and that even with repeated episodes of acute pancreatitis, pancreatic function may be slow to decline.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174715     DOI: 10.1210/jc.2005-1098

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

2.  Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.

Authors:  Jong-Gil Park; Xu Xu; Sungyun Cho; Ann-Hwee Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

3.  Lipoprotein lipase deficiency with visceral xanthomas.

Authors:  Sabah Servaes; Richard Bellah; Ritu Verma; Bruce Pawel
Journal:  Pediatr Radiol       Date:  2010-02-09

4.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

5.  Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.

Authors:  O Helk; R Schreiber; K Widhalm
Journal:  Eur J Clin Nutr       Date:  2016-05-18       Impact factor: 4.016

6.  Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

Authors:  Tatjana Josefs; Debapriya Basu; Tomas Vaisar; Britt Arets; Jenny E Kanter; Lesley-Ann Huggins; Yunying Hu; Jianhua Liu; Noemie Clouet-Foraison; Jay W Heinecke; Karin E Bornfeldt; Ira J Goldberg; Edward A Fisher
Journal:  Circ Res       Date:  2021-02-03       Impact factor: 17.367

7.  Two siblings with familial chylomicronemia syndrome: disease course and effectiveness of early treatment.

Authors:  Hanan Al Azkawi; Ibrahim Alalwan
Journal:  Case Rep Med       Date:  2010-12-27

8.  Hypertriglyceridemia.

Authors:  Amanda Brahm; Robert A Hegele
Journal:  Nutrients       Date:  2013-03-22       Impact factor: 5.717

9.  Severe Hypertriglyceridemia due to a novel p.Q240H mutation in the Lipoprotein Lipase gene.

Authors:  Angela Ganan Soto; Adam McIntyre; Sungeeta Agrawal; Shara R Bialo; Robert A Hegele; Charlotte M Boney
Journal:  Lipids Health Dis       Date:  2015-09-04       Impact factor: 3.876

Review 10.  Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.

Authors:  Debapriya Basu; Karin E Bornfeldt
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.